🔎 Trials Near Me

Dachaigh › Liomfoma Neo-Hodgkin › Nebraska › Omaha

Sgrùdaidhean clionaigeach Liomfoma Neo-Hodgkin ann an Omaha, NE

Tha 14 sgrùdaidhean airson Liomfoma Neo-Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Omaha (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

A’ fastadhÌre 2
  • University of Nebraska Medical Center, Omaha
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

A’ fastadhÌre 1
  • The University of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07195916

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

A’ fastadhÌre 1/2
  • Local Institution - 0124, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06090539

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

A’ fastadhÌre 2
  • Nebraska Cancer Specialists, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06806033

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A’ fastadhÌre 1/2
  • University of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

A’ fastadhÌre 1
  • University of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

A’ fastadhÌre 3
  • University of Nebraska Medical Center (UNMC), Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • University of Nebraska Medical Center, Omaha
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Halt Aging in Survivors of Blood Cancers

A’ fastadh
  • University of Nebraska Medical Center, Omaha
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT07292272

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A’ fastadhÌre 1/2
  • Nebraska Cancer Specialists, Omaha
  • University of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT04068597

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

A’ fastadhÌre 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

A’ fastadhÌre 4
  • University Of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

A’ fastadhÌre 4
  • University Of Nebraska Medical Center, Omaha
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06876662

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Omaha
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Sgrùdaidhean Liomfoma Neo-Hodgkin ann am bailtean eile

Sgrùdaidhean eile ann an Omaha

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.